Global Bio-chem Calls 2026 AGM, Seeks Fresh Share Issuance Mandate

Global Bio-chem Technology Group Co. Ltd. ( (HK:0809) ) has shared an announcement.

Global Bio-chem Technology Group Company Limited has called its annual general meeting for 24 June 2026 in Hong Kong, where shareholders will review and approve the audited consolidated financial statements and the directors’ and auditor’s reports for the year ended 31 December 2025. Investors will also vote on the re-election of two directors, re-appointment of the auditor, and a mandate allowing the board to issue up to 20% of the company’s share capital, including potential use of treasury shares, providing the company with flexibility for future financing and capital management.

The proposed general mandate to allot, issue, and deal in shares or convertible securities, subject to limits and existing option and dividend arrangements, is designed to streamline the company’s ability to raise capital without convening separate shareholder meetings for each issuance. Approval of these resolutions would reaffirm the current governance structure while equipping the board with broader tools to support operational needs, potential expansion, or balance sheet adjustments, which may influence shareholder dilution and the company’s strategic positioning in capital markets.

More about Global Bio-chem Technology Group Co. Ltd.

Global Bio-chem Technology Group Company Limited is a Cayman Islands-incorporated company listed on the Hong Kong Stock Exchange. The group operates in the bio-chem and related processing sector, with its business overseen by a board of directors and audited by an external auditor in line with Hong Kong listing and corporate governance requirements.

Average Trading Volume: 5,040,285

Technical Sentiment Signal: Sell

Current Market Cap: HK$1.02B

For a thorough assessment of 0809 stock, go to TipRanks’ Stock Analysis page.